BSEDr Lalchandani Labs LtdMediumNeutral
Announced Fri, 5 Sept · 17:10 IST

Appointment of Secretarial Auditor

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board of Directors of Dr Lalchandani Labs Ltd, at its meeting held on September 5, 2025, approved several items. These include the 08th Annual Report and the notice for the 08th Annual General Meeting scheduled for September 30, 2025, at Gulmohar Club, New Delhi. The Board appointed Mr. Mohan Lal Gandhi (DIN: 00800786), a medical professional and former Chamber of Commerce President, as a Non-Executive Independent Director for a 5-year term. Additionally, authorised share capital was approved to be increased from Rs. 4.50 crore to Rs. 11.00 crore, a rise of Rs. 6.50 crore, subject to shareholder approval. M/s. Chauhan Pradeep & Associates, Company Secretaries, was appointed as Secretarial Auditor for 5 years (FY2025-26 to FY2029-30) and also as scrutinizer for the 08th AGM.

Likely market impact

These are largely routine governance and compliance-related decisions. The increase in authorised capital signals potential future fundraising or expansion plans, though no immediate dilution is announced. Shareholders should watch for the proposed capital utilisation in upcoming announcements.